Lista cu medicamentele neurotoxice este doar o traducere a listei folosite de pacienții cu CMT din întreaga lume. Această listă este întocmită de Centrul de Experți ai Asociației CMT SUA.

Medicamentele enumerate mai jos sunt potențial toxice pentru pacienții cu CMT. Vincristina a fost dovedită ca fiind  periculoasă și ar trebui evitată de toți pacienții cu CMT, inclusiv cei fără simptome. Taxole (paclitaxel, docetaxel, cabazitaxel) includ, de asemenea, un risc ridicat pentru persoanele cu CMT. Restul medicamentelor enumerate mai jos prezintă grade diferite de risc pentru agravarea neuropatiei CMT. Înainte de a lua orice medicament sau de a schimba medicația, toți pacienții CMT trebuie să se asigure că medicul curant este pe deplin conștient de starea lor medicală.

listă medicamente

The medications listed below are potentially toxic to CMT patients. Vincristine has been proven hazardous and should be avoided by all CMT patients, including those with no symptoms.  Taxols also pose a high risk to people with CMT. The remainder of the medications listed below present varying degrees of potential risk for worsening CMT neuropathy.

Before taking any medication or changing medication, all CMT patients should make sure the treating physician is fully aware of their medical condition.

Definite High Risk (including asymptomatic CMT)

  • Vinca alkaloids (Vincristine)
  • Taxols (paclitaxel, docetaxel, cabazitaxel)

Moderate to Significant Risk

  • Amiodarone (Cordarone)
  • Arsenic Trioxide (Trisenox)
  • Bortezomib (Velcade)
  • Brentuximab Vedotin(Adcetris)
  • Cetuximab (Erbitux)
  • Cisplatin & Oxaliplatin
  • Colchicine (extended use)
  • Dapsone
  • Didanosine (ddI, Videx)
  • Dichloroacetate
  • Disulfiram (Antabuse)
  • Eribulin (Halaven)
  • Fluoroquinolones
  • Gold salts
  • Ipilimumab (Yervoy)
  • Ixabepilone (Ixempra)
  • Leflunomide (Arava)
  • Lenalidomide (Revlimid)
  • Metronidazole/Misonidazole (extended use)
  • Nitrofurantoin (Macrodantin, Furadantin, Macrobid)
  • Nitrous oxide (inhalation abuse or Vitamin B12 deficiency)
  • Nivolumab (Opdivo)
  • Pembrolizumab (Keytruda)
  • Perhexiline (not used in U.S.)
  • Pomalidomide (Pomalyst)
  • Pyridoxine (Although megadoses [10 times or more the RDA] of Vitamin B6 may be harmful, high intakes of vitamin B6 from food sources have not been reported to cause adverse effects.) NIH Fact Sheet
  • Stavudine (d4T, Zerit)
  • Suramin
  • Thalidomide
  • Zalcitabine (ddC, Hivid)

Uncertain or Minor Risk

  • 5-Fluoracil
  • Adriamycin
  • Almitrine (not in U.S.)
  • Chloroquine
  • Cytarabine (high dose)
  • Ethambutol
  • Etoposide (VP-16)
  • Gemcitabine
  • Griseofulvin
  • Hexamethylmelamine
  • Hydralazine
  • Ifosphamide
  • Infliximab
  • Isoniazid (INH)
  • Lansoprazole (Prevacid)
  • Mefloquine
  • Omeprazole (Prilosec)
  • Penicillamine
  • Phenytoin (Dilantin)
  • Podophyllin resin
  • Sertraline (Zoloft)
  • Statins
  • Tacrolimus (FK506, ProGraf)
  • Zimeldine (not in U.S.)
  • a-Interferon

Negligible or Doubtful Risk

  • Allopurinol
  • Amitriptyline
  • Chloramphenicol
  • Chlorprothixene
  • Cimetidine
  • Clioquinil
  • Clofibrate
  • Cyclosporin A
  • Enalapril
  • Gluthethimide
  • Lithium
  • Phenelzine
  • Propafenone
  • Sulfonamides
  • Sulphasalzine

A Note about Alcohol

Alcohol was removed from the neurotoxic drug list in July 2004.  While people with CMT generally suffer no ill effects from the moderate consumption of alcohol, they should be particularly mindful of the fact that alcohol affects balance and coordination, and that overconsumption of alcohol is generally not recommend under any circumstances.  If you have questions about alcohol and your health, consult your physician.

Neurotoxic Medications and Worsening of Neuropathy:

The Charcot-Marie-Tooth Association has long maintained this “Medical Alert” list of potentially neurotoxic medications. It is published on this webpage, in the organization’s quarterly magazine, The CMTA Report, and in a brochure that is distributed along with a “Dear Medical Professional” letter advising physicians treating CMT patients that they should consider the potential risk of prescribing drugs known to have neurotoxic properties. The list is also freely copied and republished.
Click here for an in-depth summary of a study on neurotoxic medications and how they affect CMT patients.